Arcutis Biotherapeutics

$27.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 12:59 PM UTC pre-market

Why Robinhood?

You can buy or sell ARQT and other stocks, options, and ETFs commission-free!

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis.

CEO
Todd Franklin Watanabe
Employees
54
Headquarters
Westlake Village, California
Founded
2016
Market Cap
1.43B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
170.00K
High Today
$27.65
Low Today
$25.82
Open Price
$26.63
Volume
145.60K
52 Week High
$39.85
52 Week Low
$17.51

ARQT Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, After Hours

You May Also Like

EVV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure